Axogen financials
$42.44−2.12%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $69.7M | $61.5M | $59.9M | $60.1M | $56.7M | $48.6M | $49.4M | $48.6M | $47.9M | $41.4M | $42.9M | $41.3M |
| Gross profit | $50.7M | $46.2M | $44.4M | $46.0M | $42.0M | $34.9M | $37.6M | $36.4M | $35.3M | $32.6M | $32.0M | $31.7M |
| Gross margin | 72.7% | 75.2% | 74.1% | 76.6% | 74.2% | 71.9% | 76.1% | 74.9% | 73.8% | 78.8% | 74.6% | 76.8% |
| Operating income | -$2.2M | -$2.8M | -$9.8M | $1.9M | $1.7M | -$1.7M | $2.0M | -$316.0K | -$428.0K | -$4.6M | -$3.2M | -$4.0M |
| Net income | -$1.5M | -$19.6M | -$13.2M | $708.0K | $579.0K | -$3.8M | $450.0K | -$1.9M | -$1.9M | -$6.6M | -$3.9M | -$4.1M |
| Net margin | −2.2% | −31.9% | −22.0% | 1.2% | 1.0% | −7.9% | 0.9% | −3.8% | −4.0% | −16.0% | −9.1% | −9.9% |
| Diluted EPS | $-0.03 | $-0.38 | $-0.31 | $0.01 | $0.01 | $-0.08 | $0.01 | $-0.04 | $-0.04 | $-0.15 | $-0.09 | $-0.10 |
| EBITDA | -$438.0K | -$1.1M | -$8.0M | $3.6M | $3.4M | $134.0K | $3.7M | $1.4M | $1.3M | -$3.0M | -$3.2M | -$2.8M |
| Operating cash flow | $7.2M | $1.6M | $3.0M | $3.2M | $7.7M | -$13.2M | $8.7M | $3.9M | $4.2M | -$12.3M | -$211.0K | $1.6M |
| Free cash flow | $6.3M | -$1.2M | $1.8M | $1.7M | $7.0M | -$13.4M | $8.1M | $3.3M | $3.3M | -$13.2M | -$1.7M | -$2.1M |
| Diluted shares | 53.3M | 51.6M | 41.9M | 49.1M | 48.0M | 45.2M | 46.2M | 43.9M | 43.7M | 43.2M | 43.1M | 43.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $94.6M | $82.7M | $35.5M | $23.9M | $20.0M | $18.1M |
| Short-term investments | $16.8M | $18.9M | $6.0M | $11.9M | $9.9M | $4.0M |
| Total debt | $0.00 | $0.00 | $48.4M | $48.2M | $47.9M | $47.7M |
| Total assets | $304.9M | $289.5M | $221.7M | $216.4M | $205.5M | $196.2M |
| Total liabilities | $48.6M | $44.7M | $92.8M | $95.6M | $93.2M | $90.8M |
| Shareholders' equity | $256.3M | $244.8M | $128.8M | $120.8M | $112.3M | $105.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology